Login to Your Account

Other News to Note

Wednesday, January 15, 2014

Mezzion Pharma Co. Ltd., of Seoul, South Korea, said it signed a deal with New England Research Institutes Inc., which is authorized by the National Heart, Lung and Blood Institute (NHLBI)-supported Pediatric Heart Network to manage and conduct clinical trials.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription